BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that Howard Weisman, the Company’s Chairman and Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Monday, September 22 at 4:30 p.m. ET. The conference will be held from September 22 - 25, 2008 at the Grand Hyatt New York, Park Avenue at Grand Central.
